You are here
Home 🌿 Medical Cannabis News 🌿 Healthtech company Veriheal releases gender-focused medical cannabis preference report 🌿Healthtech company Veriheal releases gender-focused medical cannabis preference report
Veriheal’s Anonymous National Survey Data Show Which Cannabis Product Categories Are Most Sought, Coupled With Patient Quality of Life Goals
Healthcare technology company Veriheal today announced findings from its annual Medical Cannabis Preference Report, a segmented survey of registered medical cannabis patients that illuminates which types of cannabis products are preferred by men and women and what product offerings patients most hope to see available in dispensaries.
Veriheal possesses the largest network of physicians in the medical cannabis space and helps patients book appointments for medical cannabis card certifications and wellness visits. The company drew data from 125,000 patient signups registered in 2021, surveying cannabis use preferences, user experience, medical conditions and several other variables which factor into their cannabis use.
The findings in the Report include a strong preference by men for cannabis flower over edibles, while women are more agnostic. However, roughly 30% of patients surveyed would prefer to see more edibles on the market, compared to an average of 21.5% of respondents who said they wished more flower were available.
Veriheal’s Report offers specificity of data at the intersection of health and cannabis that has historically been hard to come by.
“Veriheal seeks to give the patient community a voice, while also boosting research that helps cannabis companies make better, more tailored products and connect patients with the medicine they need,” said Anthony Dutcher, Veriheal CMO.
Other data findings touched on patient health goals. Men listed pain relief (69%) and relaxation (67%) most frequently, while women led with symptom relief of stress (72%) and pain (69%). Women were also more likely to utilize medical cannabis for sleep and nausea than men.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.